| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 315 |
| 1 | RANITIDINE HYDROCHLORIDE | 111 |
| 2 | ASPIRIN | 14 |
| 3 | ASPIRIN 325 MG | 13 |
| 4 | ASPIRIN 81 MG | 13 |
| 5 | ADALIMUMAB | 11 |
| 6 | PREDNISONE | 10 |
| 7 | BISOPROLOL FUMARATE | 9 |
| 8 | DAPAGLIFLOZIN | 9 |
| 9 | ETANERCEPT | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-TTWE | 2 | 0.0105 |
| 1 | TEBENTAFUSP | 3 | 0.0050 |
| 2 | PALTUSOTINE | 1 | 0.0042 |
| 3 | ALLIUM CEPA 5X, ZINCUM ACETICUM 2X, ZINCUM GLUCONIUM 1X | 1 | 0.0024 |
| 4 | ZINC ACETATE ANHYDROUS, ECHINACEA ANGUSTIFOLIA, AND ZINC GLUCONATE | 1 | 0.0024 |
| 5 | ZINC ACETATE ANHYDROUS AND ZINC GLUCONATE | 1 | 0.0023 |
| 6 | RANITIDINE HYDROCHLORIDE | 111 | 0.0020 |
| 7 | RANITIDINE | 315 | 0.0016 |
| 8 | ELAFIBRANOR | 1 | 0.0011 |
| 9 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 1 | Insulin Analog [EPC] | 15 |
| 2 | Interleukin-23 Antagonist [EPC] | 15 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 13 |
| 5 | Corticosteroid [EPC] | 13 |
| 6 | GLP-1 Receptor Agonist [EPC] | 10 |
| 7 | Kinase Inhibitor [EPC] | 10 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 9 | Benzodiazepine [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 3 | 0.0050 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 3 | Oxytocic [EPC] | 2 | 0.0007 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 7 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 8 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |